Blockade of cholinergic muscarinic receptors by pirenzepine and GHRH-induced GH secretion in the acute and recovery phase of anorexia nervosa and atypical eating disorders

[1]  B. J. Winer.  Statistical Principles in Experimental Design , 1992 .

[2]  H. Wechsler,et al.  THE DEPRESSION RATING SCALE: A QUANTITATIVE APPROACH TO THE ASSESSMENT OF DEPRESSIVE SYMPTOMATOLOGY. , 1963, Archives of general psychiatry.

[3]  V. Wynn,et al.  The plasma sugar, free fatty acid, cortisol, and growth hormone response to insulin, and the comparison of this procedure with other tests of pituitary and adrenal function. II. In patients with hypothalamic or pituitary dysfunction or anorexia nervosa. , 1966, The Journal of clinical investigation.

[4]  F. Grégoire,et al.  The Growth Hormone Response to Insulin Induced Hypoglycaemia in Anorexia Nervosa and Control Underweight or Normal Subjects , 1975, European journal of clinical investigation.

[5]  G. Bray,et al.  Hunger : basic mechanisms and clinical implications , 1976 .

[6]  D. Cantwell,et al.  Anorexia nervosa. An affective disorder? , 1977, Archives of general psychiatry.

[7]  J. Katz,et al.  LHRH Responsiveness in Anorexia Nervosa: Intactness Despite Prepubertal Circadian LH Pattern , 1977, Psychosomatic medicine.

[8]  N. Freinkel,et al.  Studies of growth hormone (GH), Thyrotropin (TSH) and prolactin (PRL) secretion in anorexia nervosa , 1978, Psychoneuroendocrinology.

[9]  J. Katz,et al.  Weight and Circadian Luteinizing Hormone Secretory Pattern in Anorexia Nervosa , 1978, Psychosomatic medicine.

[10]  R. Casper,et al.  Pretreatment Predictors of Outcome in Anorexia Nervosa , 1979, British Journal of Psychiatry.

[11]  N. Birdsall,et al.  Pirenzepine distinguishes between different subclasses of muscarinic receptors , 1980, Nature.

[12]  Schooler Nr.  How generalizable are the results of clinical trials , 1980 .

[13]  L. Judd,et al.  Increased vulnerability to cholinergic stimulation in affective-disorder patients [proceedings]. , 1980, Psychopharmacology bulletin.

[14]  J. Nurnberger,et al.  Faster cholinergic REM sleep induction in euthymic patients with primary affective illness. , 1980, Science.

[15]  C. Thaw,et al.  Acetylcholine inhibits the release of somatostatin from rat hypothalamus in vitro. , 1980, Endocrinology.

[16]  R L Hintz,et al.  Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary. , 1981, Science.

[17]  K. Halmi,et al.  Amenorrhea in anorexia nervosa: examination of the critical body weight hypothesis. , 1982, Biological psychiatry.

[18]  L. Frohman,et al.  Delayed TSH release in anorexia nervosa following injection of thyrotropin-releasing hormone (TRH) , 1982, Psychoneuroendocrinology.

[19]  W. Tamborlane,et al.  Pituitary Response to Growth Hormone–releasing Factor in Diabetes: Failure of Glucose-mediated Suppression , 1984, Diabetes.

[20]  E. Ghigo,et al.  Blockade of hp-GRF-40-induced GH release in normal men by a cholinergic muscarinic antagonist. , 1984, The Journal of clinical endocrinology and metabolism.

[21]  Francesca Brambilla,et al.  Neuroendocrine and psychopathological measures in anorexia nervosa: Resemblances to primary affective disorders , 1985, Psychiatry Research.

[22]  E. Ghigo,et al.  Cholinergic agonist and antagonist drugs modulate the growth hormone response to growth hormone-releasing hormone in the rat: evidence for mediation by somatostatin. , 1986, The Journal of endocrinology.

[23]  E. Ghigo,et al.  Potentiation of cholinergic tone by pyridostigmine bromide re-instates and potentiates the growth hormone responsiveness to intermittent administration of growth hormone-releasing factor in man. , 1986, Acta endocrinologica.

[24]  E. Ghigo,et al.  Cholinergic involvement in the growth hormone releasing hormone-induced growth hormone release: studies in normal and acromegalic subjects. , 1986, Neuroendocrinology.

[25]  B. Burguera,et al.  GROWTH HORMONE AND PROLACTIN SECRETION AFTER GROWTH HORMONE‐RELEASING HORMONE ADMINISTRATION, IN ANOREXIA NERVOSA PATIENTS, NORMAL CONTROLS AND TAMOXIFEN‐PRETREATED VOLUNTEERS , 1987, Clinical endocrinology.

[26]  E. Ghigo,et al.  GROWTH HORMONE RESPONSES TO PYRIDOSTIGMINE IN NORMAL ADULTS AND IN NORMAL AND SHORT CHILDREN , 1987, Clinical endocrinology.

[27]  C. Invitti,et al.  Clonidine stimulation in anorexia nervosa: Growth hormone, cortisol, and beta-endorphin responses , 1987, Psychiatry Research.

[28]  N. Kiriike,et al.  Thyrotropin, prolactin, and growth hormone responses to thyrotropin-releasing hormone in anorexia nervosa and bulimia , 1987, Biological Psychiatry.

[29]  E. Ghigo,et al.  Involvement of the somatostatin and cholinergic systems in the mechanism of growth hormone autofeedback regulation in the rat. , 1988, The Journal of endocrinology.

[30]  M. Hotta,et al.  Study on the mechanism of abnormal growth hormone (GH) secretion in anorexia nervosa: no evidence of involvement of a low somatomedin-C level in the abnormal GH secretion , 1988, Journal of endocrinological investigation.

[31]  R. Giorgino,et al.  Excessive sweating: a misinterpreted sign of pheochromocytoma , 1989, Journal of endocrinological investigation.

[32]  D. Cocchi,et al.  α2-Adrenoceptor sensitivity in anorexia nervosa: GH response to clonidine or ghrh stimulation , 1989, Biological Psychiatry.

[33]  G. Komaki,et al.  Effect of cholinergic muscarinic receptor blockade on human growth hormone (GH)-releasing hormone-(1-44)-induced GH secretion in anorexia nervosa. , 1990, The Journal of clinical endocrinology and metabolism.

[34]  M. Jacobson,et al.  Blunted growth hormone responses to clonidine in adolescent girls with early anorexia nervosa. Evidence for an early hypothalamic defect. , 1990, Journal of adolescent health care : official publication of the Society for Adolescent Medicine.

[35]  E. Ferrannini,et al.  Failure of glucose infusion to suppress the exaggerated GH response to GHRH in patients with anorexia nervosa , 1990, Biological Psychiatry.

[36]  F. Casanueva,et al.  Effect of enhancement of endogenous cholinergic tone with pyridostigmine on the dose-response relationships of growth hormone (GH)-releasing hormone-induced GH secretion in normal subjects. , 1990, The Journal of clinical endocrinology and metabolism.